Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.8391
-0.0019 (-0.23%)
Oct 9, 2025, 4:00 PM EDT - Market closed

Xilio Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Buy
Price Target
$3.00
Upside
+257.53%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Buy
Initiates
$2
BuyInitiates$2+138.35%Aug 6, 2025
Raymond James
Raymond James
Buy
Maintains
$6$4
BuyMaintains$6$4+376.70%Nov 8, 2024
Chardan Capital
Chardan Capital
Strong Buy
Reiterates
$7
Strong BuyReiterates$7+734.23%May 30, 2023
Chardan Capital
Chardan Capital
Strong Buy
Reiterates
$7
Strong BuyReiterates$7+734.23%May 11, 2023
Morgan Stanley
Morgan Stanley
Buy
Maintains
$20$10
BuyMaintains$20$10+1,091.75%Jan 27, 2023
Chardan Capital
Chardan Capital
Strong Buy
Initiates
$7
Strong BuyInitiates$7+734.23%Dec 21, 2022
Raymond James
Raymond James
Buy
Maintains
$31$13
BuyMaintains$31$13+1,449.28%Nov 10, 2022
Morgan Stanley
Morgan Stanley
Buy
Maintains
$32$20
BuyMaintains$32$20+2,283.51%Aug 10, 2022
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$36
Strong BuyInitiates$36+4,190.31%Jan 10, 2022
Raymond James
Raymond James
Buy
Initiates
$31
BuyInitiates$31+3,594.43%Nov 16, 2021
Cowen & Co.
Cowen & Co.
Buy
Initiates
n/a
BuyInitiatesn/an/aNov 16, 2021
Morgan Stanley
Morgan Stanley
Buy
Initiates
$32
BuyInitiates$32+3,713.61%Nov 16, 2021